Renalytix Plc
RNLX · NASDAQ
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $13,571 | $120,027 | $83,278 | $1,093,483 |
| - Cash | $4,680 | $24,682 | $41,333 | $65,159 |
| + Debt | $8,535 | $12,150 | $12,707 | $352 |
| Enterprise Value | $17,426 | $107,495 | $54,652 | $1,028,676 |
| Revenue | $2,289 | $3,403 | $2,970 | $1,491 |
| % Growth | -32.7% | 14.6% | 99.2% | – |
| Gross Profit | $156 | $701 | $918 | $687 |
| % Margin | 6.8% | 20.6% | 30.9% | 46.1% |
| EBITDA | -$28,521 | -$41,713 | -$52,694 | -$35,503 |
| % Margin | -1,246% | -1,225.8% | -1,774.2% | -2,381.2% |
| Net Income | -$33,456 | -$45,607 | -$45,276 | -$34,725 |
| % Margin | -1,461.6% | -1,340.2% | -1,524.4% | -2,329% |
| EPS Diluted | -0.62 | -1.1 | -1.34 | -0.98 |
| % Growth | 43.6% | 17.9% | -36.7% | – |
| Operating Cash Flow | -$30,111 | -$32,674 | -$45,745 | -$24,632 |
| Capital Expenditures | -$4 | $0 | -$694 | -$1,630 |
| Free Cash Flow | -$30,115 | -$32,674 | -$46,439 | -$26,262 |